Back
Theravance Biopharma Vs. Madrigal Pharmaceuticals Industry Stock Comparison
Buy
70
TBPH
Theravance Biopharma
Last Price:
10.04
Seasonality Move:
7.6%
Buy
53
MDGL
Madrigal Pharmaceuticals
Last Price:
306.20
Seasonality Move:
22.96%
Buy
70
Theravance Biopharma (TBPH)
is a Buy
Is Theravance Biopharma a Buy, Sell or Hold?
- The current Theravance Biopharma [TBPH] share price is $10.04. The Score for TBPH is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
- TBPH is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
53
Madrigal Pharmaceuticals (MDGL)
is a Buy
Is Madrigal Pharmaceuticals a Buy, Sell or Hold?
- The current Madrigal Pharmaceuticals [MDGL] share price is $306.55. The Score for MDGL is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
- MDGL is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
TBPH Stock Price Chart
What is Theravance Biopharma's stock price today?
-
The Theravance Biopharma share price today is $10.04
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TBPH is experiencing slight buying pressure.
MDGL Stock Price Chart
What is Madrigal Pharmaceuticals's stock price today?
-
The Madrigal Pharmaceuticals share price today is $306.55
The current trend is moderately bearish and MDGL is experiencing selling pressure, which indicates risk of future bearish movement.
TBPH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.29 | Buy |
| Relative Strength Index (14 RSI): | 63.64 | Buy |
| Chaikin Money Flow: | 21611 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (9.12 - 9.9) | Buy |
| Bollinger Bands (100): | (7.96 - 9.5) | Buy |
MDGL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 7.79 | Buy |
| Relative Strength Index (14 RSI): | 48.76 | Sell |
| Chaikin Money Flow: | -152909 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (308.22 - 340.76) | Sell |
| Bollinger Bands (100): | (217.64 - 307.22) | Buy |
TBPH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 9.84 | Buy |
| 20-day SMA: | 9.67 | Buy |
| 50-day SMA: | 8.95 | Buy |
| 200-day SMA: | 8.88 | Buy |
| 8-day EMA: | 9.86 | Buy |
| 20-day EMA: | 9.59 | Buy |
| 50-day EMA: | 9.15 | Buy |
| 200-day EMA: | 9.01 | Buy |
MDGL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 316.26 | Sell |
| 20-day SMA: | 319.47 | Sell |
| 50-day SMA: | 276.05 | Buy |
| 200-day SMA: | 255.28 | Buy |
| 8-day EMA: | 316.3 | Sell |
| 20-day EMA: | 314.65 | Sell |
| 50-day EMA: | 291.67 | Buy |
| 200-day EMA: | 255.84 | Buy |
Theravance Biopharma Earnings Growth & TBPH Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.33 per share, and an increase next year of $1.08 per share.
Madrigal Pharmaceuticals Earnings Growth & MDGL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $4.20 per share, a decrease next quarter of $0.00 per share, a decrease this year of $4.12 per share, and an increase next year of $10.27 per share.
Theravance Biopharma Technical Analysis
| Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Madrigal Pharmaceuticals Technical Analysis
| Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||